# Ipamorelin FAQ: Hunger, Gut Motility, Safety, and the Stack > Ipamorelin FAQ: does it make you hungry, does it help gut motility, is it FDA approved, how long it lasts, and the CJC-1295 questions — direct, cited answers. The real questions people ask about Ipamorelin — answered directly, with a citation wherever there's a number. ## Why is ipamorelin being discontinued? Ipamorelin was never an approved, marketed drug, so it isn't being "discontinued" in the usual sense — its clinical *development* simply stopped. The only published Phase 2 trial (114 bowel-resection patients, 0.03 mg/kg IV twice daily) missed its primary endpoint: time to first tolerated meal was 25.3 h versus 32.6 h on placebo (p=0.15) [3]. With efficacy unproven, no further trials followed. ## Will I gain weight on ipamorelin? There's no human trial answering this, and this site gives no personal predictions. Mechanistically the signal cuts toward weight *gain*: in mice, two weeks of ipamorelin raised body weight ~15% and elevated fat-pad weight and leptin even without growth hormone [17], and the ghrelin-receptor class activates appetite centers [18]. Any individual outcome is unpredictable and entangled with diet and training. ## Does ipamorelin help with gut motility? In animals, yes — that's its best-studied effect. Rat studies showed ipamorelin accelerated gastric emptying and increased stool output and food intake in post-surgical ileus models [9][10]. But the one human trial built on that rationale missed its goal [3], so "helps gut motility" is well-supported in rodents and unproven in people. ## What is ipamorelin? Ipamorelin is a synthetic five-amino-acid peptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that activates the ghrelin / GHS-R1a receptor to release a clean pulse of growth hormone — without raising cortisol or prolactin even at doses 200-fold above its GH dose [1]. It's the first highly GH-selective growth hormone secretagogue, and it is not an approved drug. ## What does ipamorelin do for you? In the research, ipamorelin releases growth hormone selectively [1] and, via the same ghrelin receptor, signals the gut to move [9][10]. "For you" is the wrong frame, though: there's no proven human benefit. The one human efficacy trial missed its endpoint [3], and popular benefits like sleep and recovery are anecdotal, not clinical findings. ## What is ipamorelin peptide? It's the same thing as ipamorelin — a synthetic pentapeptide and selective growth hormone secretagogue that mimics the hunger hormone ghrelin at the GHS-R1a receptor [1]. "Peptide" just names what kind of molecule it is: a short chain of amino acids, here only five long, designed to resist enzymatic breakdown. ## What are the risks of ipamorelin? The honest answer is that long-term human risk is uncharacterized — no Phase 3, no long safety database [3]. Documented concerns are mechanistic or class-level: a chronic heart-muscle signal in rats from a related ghrelin-receptor compound [6], theoretical IGF-1-and-cancer concerns [1], and blood-sugar effects from a direct pancreatic action [16]. See the cited cautions on [Ipamorelin effects](/effects). ## Does ipamorelin reduce belly fat? No human trial shows ipamorelin reduces belly fat. The closest recent data is a 2024 ferret study where ipamorelin (1–3 mg/kg) blunted chemotherapy-induced weight *loss* by ~24% — the opposite context [5]. Mechanistically it even stimulates fat tissue and appetite in mice [17], so a clean "burns belly fat" claim isn't supported by the evidence. ## What are the downsides of ipamorelin? On the reported side (anecdotal): facial flushing, increased hunger, tingling, mild water retention, and grogginess after a dose. On the cited side: unproven human efficacy [3], a class-level cardiac signal [6], and unpredictable glucose effects [16]. The biggest downside is simply how thin the human evidence is. Full breakdown on [Ipamorelin effects](/effects). ## What does CJC-1295 and ipamorelin do? Together they're meant to raise growth hormone through two different receptors at once: ipamorelin flips the ghrelin receptor [1] while CJC-1295 (a long-acting GHRH analog) flips the GHRH receptor. The pairing is mechanistically logical, but no published trial has tested the combination for any outcome — the rationale rests on each drug's separate pharmacology. ## Does ipamorelin increase IGF-1? Not reliably in short studies. Ipamorelin pulses growth hormone, which *can* feed liver IGF-1 — but several rodent studies found no measurable rise in total IGF-1 despite clear GH and skeletal effects [4]. That suggests some of ipamorelin's actions are local or pulse-driven rather than showing up as a systemic IGF-1 increase. ## How does CJC-1295 ipamorelin work? Two switches, one goal. Ipamorelin activates the ghrelin/GHS-R1a receptor on pituitary and gut cells [1][9], releasing a pulse of growth hormone cleanly [1]. CJC-1295 activates the separate GHRH receptor and acts long-acting. Combined, the idea is a bigger, more natural GH release from hitting both pathways — though the combination itself is untested in trials. ## How much CJC-1295 ipamorelin should I take? This site doesn't provide doses, and no controlled human trial has established one for the combination. The doses that circulate online are community conventions, not study results [3]. The only ipamorelin amounts with published grounding are the study doses given IV to volunteers and animals under research conditions [2]. See [Ipamorelin dosage](/dosage). ## Does CJC-1295 ipamorelin work? For raising growth hormone short-term, the single-agent pharmacology of each is real [1][2]. For any actual outcome — sleep, fat loss, recovery — the combination has never been tested in a published trial, and ipamorelin's one human efficacy trial missed its endpoint [3]. So "works" is supported for mechanism, unproven for benefits. ## How to reconstitute CJC-1295 ipamorelin 5mg? In research-supply handling, ipamorelin ships as a lyophilized (freeze-dried) powder and is mixed with bacteriostatic water; as a peptide it's kept refrigerated and protected from freeze-thaw [2]. These are general lab-handling notes, not a human-use preparation instruction, and this site offers no step-by-step protocol. See [Ipamorelin dosage](/dosage) for the study-grounded kinetics. ## How long does ipamorelin stay in your system? In healthy human volunteers, ipamorelin's terminal half-life is about 2 hours after IV dosing, with clearance 0.078 L/h/kg [2]. The growth-hormone pulse it triggers peaks around 40 minutes post-dose and is a single discrete spike [2]. So the peptide itself clears within hours, though it's also detectable in urine by anti-doping labs. ## Does ipamorelin make you hungry? It can, mechanistically — it activates the ghrelin (hunger-hormone) receptor, and that receptor class drives feeding in animals [18][17]. Community reports describe increased hunger as milder than with GHRP-6 (anecdotal). There's no human appetite trial, but the mechanism makes appetite a real and expected effect. Full deep dive: [does ipamorelin make you hungry](/appetite). ## Does ipamorelin increase appetite? By mechanism, yes. Ghrelin-receptor agonists activate the brain's appetite centers and induce feeding [18], and ipamorelin stimulated fat tissue, leptin, and weight gain in mice independent of growth hormone [17]. How strongly any person notices it varies, and no controlled human appetite study exists — but the appetite signal is built into the receptor it targets. ## What does ipamorelin peptide do? It selectively releases growth hormone by activating the ghrelin/GHS-R1a receptor [1], and through that same receptor it signals the gut to move, accelerating gastric emptying in animal studies [9][10]. It does this without the cortisol and prolactin spillover of older peptides [1]. What it does *not* have is a proven human benefit — its one efficacy trial missed its goal [3]. ## How long does it take for ipamorelin to work? Pharmacologically it acts fast: the growth-hormone pulse peaks about 40 minutes after an IV dose in humans [2]. "Working" in the sense of producing the benefits people seek is a different question with no controlled-trial answer — anecdotal reports of sleep changes often appear within a week or two, but those are stories, not measured findings. ## Does ipamorelin cause water retention? Mild water retention is reported anecdotally, especially in the first few weeks, and described as milder than with older GHRP compounds. There's a plausible basis: growth-hormone excess is linked to sodium and water retention. But the only controlled human trial (a short perioperative window) showed no ipamorelin-specific safety signal [3], so this rests on mechanism and community reports, not a measured finding. ## Where to inject CJC-1295 ipamorelin? This site doesn't give injection instructions or protocols. For context only: in research, the dominant route for ipamorelin is subcutaneous (under the skin), with IV used in human PK and clinical studies and intraperitoneal used in rodent work [2][9]. None of that is human-use guidance — it's a description of how studies administered the compound. --- A bright, plain-English reading of the ipamorelin research — the clean GH pulse and the gut-motility data up front, the lone failed human trial and the missing long-term safety in plain sight; no clinic, no prescription, and absolutely nothing for sale.